Currently, there are 211.14M common shares owned by the public and among those 206.12M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 11.63% and -4.71% over the past three months. GENI shares are trading 7.63% year to date (YTD), with the 12-month market performance up to 30.94% higher. It has a 12-month low price of $4.91 and touched a high of $10.33 over the same period. GENI has an average intraday trading volume of 2.24 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.80%, 4.19%, and 23.15% respectively.
Institutional ownership of Genius Sports Limited (NYSE: GENI) shares accounts for 80.31% of the company’s 211.14M shares outstanding.
It has a market capitalization of $2.30B and a beta (3y monthly) value of 2.15. The earnings-per-share (ttm) stands at -$0.32. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.98% over the week and 4.79% over the month.
Earnings per share for the fiscal year are expected to increase by 106.59%, and 796.28% over the next financial year.
Looking at the support for the GENI, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on June 13, 2024, with the firm’s price target at $9. Goldman coverage for the Genius Sports Limited (GENI) stock in a research note released on April 16, 2024 offered a Buy rating with a price target of $7.50. B. Riley Securities was of a view on April 05, 2024 that the stock is Buy, while Macquarie gave the stock Outperform rating on December 21, 2023, issuing a price target of $11. Cantor Fitzgerald on their part issued Overweight rating on October 12, 2023.
